We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Poloxamer 188 for Sickle Cell Disease.
- Authors
Zylke, Jody
- Abstract
The author discusses a study by J. F. Casella and colleagues, published within the issue on the results of phase 3, randomized, placebo-controlled clinical trial of poloxamer 188 conducted in 66 hospitals in 12 countries. Topics include the primary outcome of the trial, explanations for the different conclusions of the trials, and the need to publish results of studies, especially clinical trials that are time and resource intensive, in a peer reviewed journal.
- Subjects
CLINICAL trials; POLOXAMERS; ETHYLENE glycols; NONIONIC surfactants; PLACEBOS
- Publication
JAMA: Journal of the American Medical Association, 2021, Vol 325, Issue 15, p1524
- ISSN
0098-7484
- Publication type
journal article
- DOI
10.1001/jama.2021.3399